{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:39:39Z","timestamp":1791322779384,"version":"4.3.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["726368"],"award-info":[{"award-number":["726368"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jmb.2025.169048","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:14:53Z","timestamp":1740500093000},"page":"169048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Off-pathway oligomers of <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" altimg=\"si24.svg\"><mml:mrow><mml:mi>\u03b1<\/mml:mi><\/mml:mrow><\/mml:math>-synuclein and A<mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" altimg=\"si25.svg\"><mml:mrow><mml:mi>\u03b2<\/mml:mi><\/mml:mrow><\/mml:math> inhibit secondary nucleation of <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" altimg=\"si26.svg\"><mml:mrow><mml:mi>\u03b1<\/mml:mi><\/mml:mrow><\/mml:math>-synuclein amyloid fibrils"],"prefix":"10.1016","volume":"437","author":[{"given":"Marie P.","family":"Sch\u00fctzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jmb.2025.169048_b0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.jmb.2025.169048_b0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-Abeta component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.jmb.2025.169048_b0015","doi-asserted-by":"crossref","unstructured":"International Parkinson\u2019s Disease Genomics Consortium (IPDGC), Parkinson\u2019s Study Group (PSG) Parkinson\u2019s Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), The Ashkenazi Jewish Dataset Investigator, Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE), North American Brain Expression Consortium (NABEC), United Kingdom Brain Expression Consortium (UKBEC), Greek Parkinson\u2019s Disease Consortium, Alzheimer Genetic Analysis Group, M.A. Nalls, N. Pankratz, C.M. Lill, C.B. Do, D.G. Hernandez, M. Saad, A.L. DeStefano, E. Kara, J. Bras, M. Sharma, C. Schulte, M.F. Keller, S. Arepalli, C. Letson, C. Edsall, H. Stefansson, X. Liu, H. Pliner, J.H. Lee, R. Cheng, M.A. Ikram, J.P.A. Ioannidis, G.M. Hadjigeorgiou, J.C. Bis, M. Martinez, J.S. Perlmutter, A. Goate, K. Marder, B. Fiske, M. Sutherland, G. Xiromerisiou, R.H. Myers, L.N. Clark, K. Stefansson, J.A. Hardy, P. Heutink, H. Chen, N.W. Wood, H. Houlden, H. Payami, A. Brice, W.K. Scott, T. Gasser, L. Bertram, N. Eriksson, T. Foroud, A.B. Singleton, Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease, Nat. Genet. 46 (9) (2014) 989\u2013993. doi:10.1038\/ng.3043.","DOI":"10.1038\/ng.3043"},{"issue":"5290","key":"10.1016\/j.jmb.2025.169048_b0020","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson\u2019s disease to chromosome 4q21-q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"issue":"342","key":"10.1016\/j.jmb.2025.169048_b0025","doi-asserted-by":"crossref","first-page":"(Jun","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"Alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.jmb.2025.169048_b0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bbapap.2018.10.006","article-title":"Disruptive membrane interactions of alpha-synuclein aggregates","volume":"1867","author":"Iyer","year":"2019","journal-title":"Biochim. et Biophys. Acta (BBA)-Prot. Proteom."},{"issue":"3","key":"10.1016\/j.jmb.2025.169048_b0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10.1016\/j.jmb.2025.169048_b0040","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/ncomms3575","article-title":"Structural and functional characterization of two alpha-synuclein strains","volume":"4","author":"Bousset","year":"2013","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jmb.2025.169048_b0045","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","article-title":"Cryo-em of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"issue":"7933","key":"10.1016\/j.jmb.2025.169048_b0050","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","article-title":"Structures of \u03b1-synuclein filaments from human brains with lewy pathology","volume":"610","author":"Yang","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jmb.2025.169048_b0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: a new hope","volume":"134","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jmb.2025.169048_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00408","article-title":"Alpha-synuclein oligomers\u2014neurotoxic molecules in Parkinson\u2019s disease and other Lewy body disorders","volume":"10","author":"Ingelsson","year":"2016","journal-title":"Front. Neurosci."},{"issue":"s1","key":"10.1016\/j.jmb.2025.169048_b0065","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The Amyloid-\u03b2 oligomer hypothesis: beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J. Alzheimer\u2019s Disease: JAD"},{"issue":"04","key":"10.1016\/j.jmb.2025.169048_b0070","doi-asserted-by":"crossref","DOI":"10.4172\/2161-0460.1000444","article-title":"The contribution of Tau, Amyloid-Beta and Alpha-Synuclein pathology to dementia in lewy body disorders","volume":"08","author":"Irwin","year":"2018","journal-title":"J. Alzheimer\u2019s Disease & Parkinson."},{"issue":"21","key":"10.1016\/j.jmb.2025.169048_b0075","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between A\u03b2, Tau, and \u03b1-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jmb.2025.169048_b0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol. (Zurich, Switzerland)"},{"issue":"9","key":"10.1016\/j.jmb.2025.169048_b0085","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.jmb.2025.169048_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.biomac.2c01233","article-title":"Amyloid protein cross-seeding provides a new perspective on multiple diseases in vivo","volume":"24","author":"Ge","year":"2023","journal-title":"Biomacromolecules"},{"issue":"3","key":"10.1016\/j.jmb.2025.169048_b0095","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/molecules25030580","article-title":"Amyloid-beta peptides trigger aggregation of alpha-synuclein in vitro","volume":"25","author":"K\u00f6ppen","year":"2020","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.jmb.2025.169048_b0100","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","article-title":"beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"98","author":"Masliah","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.jmb.2025.169048_b0105","doi-asserted-by":"crossref","first-page":"10215","DOI":"10.3390\/ijms241210215","article-title":"The mechanisms of the roles of \u03b1-synuclein, amyloid-\u03b2, and tau protein in the lewy body diseases: pathogenesis, early detection, and therapeutics","volume":"24","author":"Noguchi-Shinohara","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.jmb.2025.169048_b0110","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","article-title":"Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer\u2019s and Parkinson\u2019s in dementia with Lewy body disease","volume":"31","author":"Mandal","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jmb.2025.169048_b0115","doi-asserted-by":"crossref","unstructured":"P.H. Jensen, P. Hojrup, H. Hager, M.S. Nielsen, L. Jacobsen, O.F. Olesen, J. Gliemann, R. Jakes, Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein\/NAC precursor that bind Abeta and NAC, Biochem. J. 323 (Pt 2) (Pt 2) (1997) 539\u2013546. doi:10.1042\/bj3230539.","DOI":"10.1042\/bj3230539"},{"issue":"3","key":"10.1016\/j.jmb.2025.169048_b0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.jmb.2025.169048_b0125","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nprot.2010.72","article-title":"Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer\u2019s disease research","volume":"5","author":"Jan","year":"2010","journal-title":"Nat. Protoc."},{"issue":"24","key":"10.1016\/j.jmb.2025.169048_b0130","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1039\/C9SC06501F","article-title":"Identification of on- and off-pathway oligomers in amyloid fibril formation","volume":"11","author":"Dear","year":"2020","journal-title":"Chem. Sci."},{"issue":"27","key":"10.1016\/j.jmb.2025.169048_b0135","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1039\/C8SC01479E","article-title":"Origin of metastable oligomers and their effects on amyloid fibril self-assembly","volume":"9","author":"Hasecke","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jmb.2025.169048_b0140","doi-asserted-by":"crossref","first-page":"1120416","DOI":"10.3389\/fmolb.2023.1120416","article-title":"Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils","volume":"10","author":"Muschol","year":"2023","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.jmb.2025.169048_b0145","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/jnc.14808","article-title":"\u03b1-synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities","volume":"150","author":"Alam","year":"2019","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jmb.2025.169048_b0150","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer\u2019s disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.jmb.2025.169048_b0155","doi-asserted-by":"crossref","unstructured":"L. Forny-Germano, N.M. Lyra e Silva, A.F. Batista, J. Brito-Moreira, M. Gralle, S.E. Boehnke, B.C. Coe, A. Lablans, S.A. Marques, A.M.B. Martinez, W.L. Klein, J.-C. Houzel, S.T. Ferreira, D.P. Munoz, F.G. De Felice, Alzheimer\u2019s disease-like pathology induced by amyloid-\u03b2 oligomers in nonhuman primates, J. Neurosci.: Off. J. Soc. Neurosci. 34 (41) (2014) 13629\u201313643. doi:10.1523\/JNEUROSCI.1353-14.2014.","DOI":"10.1523\/JNEUROSCI.1353-14.2014"},{"issue":"8","key":"10.1016\/j.jmb.2025.169048_b0160","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1096\/fj.201900604R","article-title":"High molecular weight amyloid \u03b21-42 oligomers induce neurotoxicity via plasma membrane damage","volume":"33","author":"Yasumoto","year":"2019","journal-title":"FASEB J.: Off. Publicat. Federation Am. Soc. Exp. Biol."},{"issue":"14","key":"10.1016\/j.jmb.2025.169048_b0165","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1523\/JNEUROSCI.5825-09.2010","article-title":"A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo","volume":"30","author":"Tomiyama","year":"2010","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"1","key":"10.1016\/j.jmb.2025.169048_b0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13311-022-01308-6","article-title":"Lecanemab, aducanumab, and gantenerumab - binding profiles to different forms of amyloid-beta might explain efficacy and side effects in clinical trials for Alzheimer\u2019s disease","volume":"20","author":"S\u00f6derberg","year":"2023","journal-title":"Neurotherapeut.: J. Am. Soc. Exp. NeuroTherapeut."},{"issue":"1","key":"10.1016\/j.jmb.2025.169048_b0175","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1038\/s41467-021-24900-4","article-title":"Endo-lysosomal A\u03b2 concentration and pH trigger formation of A\u03b2 oligomers that potently induce Tau missorting","volume":"12","author":"Sch\u00fctzmann","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.jmb.2025.169048_b0180","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/ange.202010098","article-title":"Protofibril-fibril interactions inhibit amyloid fibril assembly by obstructing secondary nucleation","volume":"133","author":"Hasecke","year":"2021","journal-title":"Angew. Chem."},{"issue":"4","key":"10.1016\/j.jmb.2025.169048_b0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12551-017-0289-z","article-title":"Monomer-dependent secondary nucleation in amyloid formation","volume":"9","author":"Linse","year":"2017","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.jmb.2025.169048_b0190","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1017\/S0033583516000172","article-title":"Secondary nucleation of monomers on fibril surface dominates \u03b1 -synuclein aggregation and provides autocatalytic amyloid amplification","volume":"50","author":"Gaspar","year":"2017","journal-title":"Q. Rev. Biophys."},{"issue":"1","key":"10.1016\/j.jmb.2025.169048_b0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13195-017-0293-3","article-title":"Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer\u2019s disease","volume":"9","author":"Brody","year":"2017","journal-title":"Alzheimer\u2019s Res. Therapy"},{"issue":"21","key":"10.1016\/j.jmb.2025.169048_b0200","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.1315346111","article-title":"Solution conditions determine the relative importance of nucleation and growth processes in \u03b1-synuclein aggregation","volume":"111","author":"Buell","year":"2014","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"25","key":"10.1016\/j.jmb.2025.169048_b0205","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1039\/C8SC01109E","article-title":"C-terminal truncation of \u03b1-synuclein promotes amyloid fibril amplification at physiological pH","volume":"9","author":"Van Der Wateren","year":"2018","journal-title":"Chem. Sci."},{"issue":"9","key":"10.1016\/j.jmb.2025.169048_b0210","article-title":"Disordered regions of inhibitor-bound \u03b1-synuclein suppress seed-induced fibril nucleation in cells","volume":"5","author":"Schulz","year":"2024","journal-title":"Cell Rep. Phys. Sci."},{"issue":"8","key":"10.1016\/j.jmb.2025.169048_b0215","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1073\/pnas.1013225108","article-title":"Low-resolution structure of a vesicle disrupting \u03b1-synuclein oligomer that accumulates during fibrillation","volume":"108","author":"Giehm","year":"2011","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"10","key":"10.1016\/j.jmb.2025.169048_b0220","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1021\/ja411577t","article-title":"The role of stable \u03b1-synuclein oligomers in the molecular events underlying amyloid formation","volume":"136","author":"Lorenzen","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.jmb.2025.169048_b0225","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s42003-020-1085-z","article-title":"Clustering of human prion protein and \u03b1-synuclein oligomers requires the prion protein n-terminus","volume":"3","author":"R\u00f6sener","year":"2020","journal-title":"Commun. Biol."},{"issue":"18","key":"10.1016\/j.jmb.2025.169048_b0230","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017452118","article-title":"NMR unveils an N-terminal interaction interface on acetylated-\u03b1-synuclein monomers for recruitment to fibrils","volume":"118","author":"Yang","year":"2021","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"51","key":"10.1016\/j.jmb.2025.169048_b0235","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1021\/bi048453u","article-title":"Impact of the acidic c-terminal region comprising amino acids 109\u2013140 on \u03b1-synuclein aggregation in vitro","volume":"43","author":"Hoyer","year":"2004","journal-title":"Biochemistry"},{"issue":"41","key":"10.1016\/j.jmb.2025.169048_b0240","doi-asserted-by":"crossref","first-page":"25272","DOI":"10.1073\/pnas.2002956117","article-title":"The role of fibril structure and surface hydrophobicity in secondary nucleation of amyloid fibrils","volume":"117","author":"Thacker","year":"2020","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.jmb.2025.169048_b0245","doi-asserted-by":"crossref","first-page":"106519","DOI":"10.1016\/j.bpc.2020.106519","article-title":"\u03b2-turn exchanges in the \u03b1-synuclein segment 44-tkeg-47 reveal high sequence fidelity requirements of amyloid fibril elongation","volume":"269","author":"Agerschou","year":"2021","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jmb.2025.169048_b0250","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ijbiomac.2021.03.113","article-title":"The role of amyloid oligomers in neurodegenerative pathologies","volume":"181","author":"Wells","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.jmb.2025.169048_b0255","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.bbamem.2015.01.018","article-title":"Interactions between misfolded protein oligomers and membranes: a central topic in neurodegenerative diseases?","volume":"1848","author":"Andreasen","year":"2015","journal-title":"Biochim. et Biophys. Acta (BBA)-Biomembr."},{"key":"10.1016\/j.jmb.2025.169048_b0260","doi-asserted-by":"crossref","first-page":"e46112","DOI":"10.7554\/eLife.46112","article-title":"An engineered monomer binding-protein for \u03b1-synuclein efficiently inhibits the proliferation of amyloid fibrils","volume":"8","author":"Agerschou","year":"2019","journal-title":"Elife"}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283625001147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283625001147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T19:21:16Z","timestamp":1743880876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283625001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0022283625001147"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2025.169048","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Off-pathway oligomers of -synuclein and A inhibit secondary nucleation of -synuclein amyloid fibrils","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2025.169048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"169048"}}